These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25175974)

  • 1. The adenosine neuromodulation system in schizophrenia.
    Rial D; Lara DR; Cunha RA
    Int Rev Neurobiol; 2014; 119():395-449. PubMed ID: 25175974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine receptor control of cognition in normal and disease.
    Chen JF
    Int Rev Neurobiol; 2014; 119():257-307. PubMed ID: 25175970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does adenosine control neuronal dysfunction and neurodegeneration?
    Cunha RA
    J Neurochem; 2016 Dec; 139(6):1019-1055. PubMed ID: 27365148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine receptors in cerebral ischemia.
    Melani A; Pugliese AM; Pedata F
    Int Rev Neurobiol; 2014; 119():309-48. PubMed ID: 25175971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of striatal adenosine A(2A) receptors in schizophrenia.
    Deckert J; Brenner M; Durany N; Zöchling R; Paulus W; Ransmayr G; Tatschner T; Danielczyk W; Jellinger K; Riederer P
    Neuroreport; 2003 Mar; 14(3):313-6. PubMed ID: 12634474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.
    Boison D; Singer P; Shen HY; Feldon J; Yee BK
    Neuropharmacology; 2012 Mar; 62(3):1527-43. PubMed ID: 21315743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity.
    Cunha RA
    Neurochem Int; 2008 Jan; 52(1-2):65-72. PubMed ID: 17664029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic receptors in psychiatric disorders.
    Krügel U
    Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroprotective mechanisms of adenosine action on CNS neurons].
    Zalewska-Kaszubska J
    Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine receptors and epilepsy: current evidence and future potential.
    Masino SA; Kawamura M; Ruskin DN
    Int Rev Neurobiol; 2014; 119():233-55. PubMed ID: 25175969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of glial cell functions by adenosine receptors.
    Daré E; Schulte G; Karovic O; Hammarberg C; Fredholm BB
    Physiol Behav; 2007 Sep; 92(1-2):15-20. PubMed ID: 17574632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.
    Fredholm BB
    Pharmacol Toxicol; 1995 Feb; 76(2):93-101. PubMed ID: 7746802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.
    Morin N; Di Paolo T
    Int Rev Neurobiol; 2014; 119():151-67. PubMed ID: 25175965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists.
    Dixon DA; Fenix LA; Kim DM; Raffa RB
    Ann Pharmacother; 1999 Apr; 33(4):480-8. PubMed ID: 10332540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia.
    Kase H
    Biosci Biotechnol Biochem; 2001 Jul; 65(7):1447-57. PubMed ID: 11515525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation and metamodulation of synapses by adenosine.
    Ribeiro JA; Sebastião AM
    Acta Physiol (Oxf); 2010 Jun; 199(2):161-9. PubMed ID: 20345418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic administration of adenosine antagonists on adenosine A1 and A2a receptors in mouse brain.
    Traversa U; Rosati AM; Florio C; Vertua R
    In Vivo; 1994; 8(6):1073-8. PubMed ID: 7772740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators.
    Ribeiro JA
    Eur J Pharmacol; 1999 Jun; 375(1-3):101-13. PubMed ID: 10443568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine and related drugs in brain diseases: present and future in clinical trials.
    Lopes LV; Sebastião AM; Ribeiro JA
    Curr Top Med Chem; 2011; 11(8):1087-101. PubMed ID: 21401493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.
    Dalpiaz A; Gessi S; Varani K; Borea PA
    Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.